Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IWR VHT

Index	S&P 500	P/E	43.81	EPS (ttm)	1.87	Insider Own	0.68%	Shs Outstand	195.90M	Perf Week	0.88%
Market Cap	16.09B	Forward P/E	16.57	EPS next Y	4.96	Insider Trans	2.62%	Shs Float	194.64M	Perf Month	-2.15%
Enterprise Value	18.76B	PEG	1.67	EPS next Q	1.03	Inst Own	107.11%	Short Float	3.72%	Perf Quarter	19.19%
Income	374.90M	P/S	3.93	EPS this Y	9.73%	Inst Trans	2.78%	Short Ratio	2.75	Perf Half Y	18.64%
Sales	4.09B	P/B	1.95	EPS next Y	9.60%	ROA	3.03%	Short Interest	7.24M	Perf YTD	0.17%
Book/sh	42.06	P/C	145.48	EPS next 5Y	9.90%	ROE	4.59%	52W High	96.78 -15.17%	Perf Year	-15.07%
Cash/sh	0.56	P/FCF	37.10	EPS past 3/5Y	-1.15% 9.30%	ROIC	3.43%	52W Low	61.78 32.90%	Perf 3Y	-7.90%
Dividend Est.	-	EV/EBITDA	17.70	Sales past 3/5Y	7.35% 10.98%	Gross Margin	60.67%	Volatility	2.76% 2.11%	Perf 5Y	-10.05%
Dividend TTM	-	EV/Sales	4.58	EPS Y/Y TTM	-4.47%	Oper. Margin	16.69%	ATR (14)	1.84	Perf 10Y	150.40%
Dividend Ex-Date	Jul 26, 2023	Quick Ratio	1.13	Sales Y/Y TTM	5.06%	Profit Margin	9.16%	RSI (14)	54.15	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	1.89	EPS Q/Q	-26.90%	SMA20	0.80%	Beta	1.02	Target Price	90.56
Payout	0.00%	Debt/Eq	0.34	Sales Q/Q	4.60%	SMA50	1.20%	Rel Volume	0.57	Prev Close	80.10
Employees	15000	LT Debt/Eq	0.33	Earnings	Mar 05 AMC	SMA200	9.82%	Avg Volume	2.63M	Price	82.10
IPO	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.30% 0.42%	Trades		Volume	1,508,277	Change	2.50%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-26	Reiterated	Needham	Buy	$100 → $99
Nov-13-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$72
Oct-13-25	Initiated	Barclays	Overweight	$85
Oct-01-25	Initiated	Goldman	Sell	$64
Aug-28-25	Downgrade	Citigroup	Buy → Neutral	$72
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform	$92
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight

Show Previous Ratings

Feb-05-26 04:15PM	CooperCompanies Announces Release Date for First Quarter 2026 (GlobeNewswire)
Feb-04-26 05:20PM	Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Feb-03-26 01:17PM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
12:10PM	Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:05AM	Diamond Hill Large Cap Fund Purchased Cooper Companies (COO) Betting on the Resilient Contact Lens Industry (Insider Monkey)
11:57AM	Loading…
Feb-02-26 11:57AM	BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics (Zacks)
Jan-29-26 11:38PM	1 Healthcare Stock to Own for Decades and 2 We Question (StockStory)
12:17PM	CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up (Zacks)
Jan-28-26 11:40AM	COO vs. WST: Which Stock Should Value Investors Buy Now? (Zacks)
Jan-27-26 12:19PM	Here's Why You Should Add Merit Medical Stock to Your Portfolio Now (Zacks)
09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jan-26-26 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
Jan-23-26 01:50PM	WST Launches Synchrony S1 Prefillable Syringe at Pharmapack (Zacks)
07:57AM	What You Need to Know Ahead of The Cooper Companies' Earnings Release (Barchart)
Jan-22-26 11:08AM	Here's Why You Should Retain Integer Holdings Stock in Your Portfolio (Zacks)
10:43AM	Loading…
10:43AM	BD and Ypsomed Expand Partnership to Target Growing Biologics Market (Zacks)
Jan-21-26 11:43AM	BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System (Zacks)
Jan-14-26 12:50PM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Jan-13-26 11:16AM	Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial (Benzinga)
Jan-12-26 11:40AM	COO or WST: Which Is the Better Value Stock Right Now? (Zacks)
Jan-07-26 03:00PM	40 stocks likely to outperform in 2026: Boyar pres. explains (Yahoo Finance Video)
Jan-06-26 08:00AM	CooperVision to Launch MyDay MiSight 1 day Myopia Control Soft Contact Lenses (PR Newswire)
Jan-05-26 07:17AM	Hologic Trading Near 52-Week High: How Should You Play the Stock? (Zacks)
Jan-01-26 10:32PM	Medical Devices & Supplies - Diversified Stocks Q3 In Review: CooperCompanies (NASDAQ:COO) Vs Peers (StockStory)
Dec-31-25 07:36AM	What Makes The Cooper Companies (COO) an Investment Bet? (Insider Monkey)
Dec-30-25 02:04PM	Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel (Zacks)
07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
Dec-29-25 04:15PM	CooperCompanies to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-26-25 11:40AM	COO vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
Dec-23-25 08:00AM	CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors (GlobeNewswire)
12:12PM	Loading…
Dec-22-25 12:12PM	BD and Penn Institute Ink Collaboration to Advance Immunotherapy (Zacks)
Dec-19-25 09:55AM	The Cooper Companies (COO)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Dec-16-25 11:05PM	3 Reasons to Sell COO and 1 Stock to Buy Instead (StockStory)
11:37AM	BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe (Zacks)
Dec-12-25 09:50AM	Why The Cooper Companies (COO) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-11-25 07:34AM	Is The Cooper Companies Stock Underperforming the Nasdaq? (Barchart)
12:31AM	5 Insightful Analyst Questions From CooperCompanies's Q3 Earnings Call (StockStory)
Dec-10-25 11:40AM	COO or MMSI: Which Is the Better Value Stock Right Now? (Zacks)
Dec-08-25 09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
09:15AM	The Cooper Companies (COO) International Revenue Performance Explored (Zacks)
Dec-05-25 11:11AM	CooperCompanies (COO) Stock Trades Up, Here Is Why (StockStory) +5.67%
11:02AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
09:11AM	COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises (Zacks)
07:36AM	Warner Bros. shares rise on Netflix deal news, Hewlett Packard Enterprise slumps on earnings and more early market movers (MarketWatch)
02:46AM	Stock Market Today: Dow, S&P 500 and Nasdaq point to gains as investors await Fed's preferred inflation gauge; bitcoin slips, silver surges (MarketWatch)
12:31AM	COO Q3 Deep Dive: Product Momentum and Strategic Review Shape Outlook (StockStory)
12:02AM	The Cooper Companies Inc (COO) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Dec-04-25 06:30PM	The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:45PM	CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars (StockStory)
04:20PM	CooperCompanies Announces New Chair of the Board and Strategic Review (GlobeNewswire)
04:15PM	CooperCompanies Announces Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Dec-03-25 05:15PM	HealthEquity (HQY) Tops Q3 Earnings and Revenue Estimates (Zacks)
12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Dec-02-25 10:04PM	What To Expect From CooperCompanies's (COO) Q3 Earnings (StockStory)
Dec-01-25 09:15AM	Curious about The Cooper Companies (COO) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
06:11AM	1 Profitable Stock to Own for Decades and 2 We Find Risky (StockStory)
Nov-30-25 07:27AM	Stocks drift back towards record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
07:27AM	Stocks drift back toward record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
Nov-27-25 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? (Zacks)
Nov-23-25 11:36PM	1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds (StockStory)
Nov-21-25 06:36PM	CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know (StockStory) +6.13%
Nov-19-25 06:38AM	Cooper Companies Stock: Analyst Estimates & Ratings (Barchart)
Nov-14-25 05:10PM	Jana Partners' Strategic Move: Significant Addition of The Cooper Companies Inc (GuruFocus.com)
Nov-13-25 05:20PM	Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
09:45AM	Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
09:10AM	Here Are Thursdays Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More (24/7 Wall St.)
Nov-06-25 07:40AM	Becton Dickinson (BDX) Tops Q4 Earnings and Revenue Estimates (Zacks)
Nov-05-25 06:30PM	Conmed (CNMD) Tops Q3 Earnings and Revenue Estimates (Zacks)
Nov-04-25 04:15PM	CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025 (GlobeNewswire)
Nov-03-25 12:00PM	Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings? (Zacks)
Oct-31-25 10:23AM	4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks (Zacks)
Oct-28-25 01:54AM	What to Expect From Cooper Companies Next Quarterly Earnings Report (Barchart)
Oct-21-25 09:24AM	Company News for Oct 21, 2025 (Zacks)
Oct-20-25 09:34AM	Stocks to Watch Monday: Amazon, Zions Bancorp, Kering (The Wall Street Journal)
08:21AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:41AM	Cooper Cos. Stock Rises as Report Says Activist Investor Takes Stake (Barrons.com)
07:25AM	Activist Jana Pushes Big Contact-Lens Combination of Cooper and Bausch + Lomb (The Wall Street Journal)
Oct-19-25 08:00PM	Activist Jana Takes Stake in Cooper, a Maker of Medical Devices (The Wall Street Journal)
Oct-16-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-01-25 11:01AM	Goldman Sachs initiates ophthalmology coverage: Buy Glaukos, sell Cooper (Investing.com)
Sep-26-25 11:30AM	The Cooper Companies (COO) Up 3.6% Since Last Earnings Report: Can It Continue? (Zacks)
12:39AM	3 Healthcare Stocks That Fall Short (StockStory)
Sep-22-25 09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
Sep-19-25 01:55AM	Is Cooper Companies Stock Underperforming the S&P 500? (Barchart)
Sep-18-25 11:42AM	Why CooperCompanies (COO) Stock Is Up Today (StockStory)
Sep-17-25 04:15PM	CooperCompanies Announces Expanded Share Repurchase Program (GlobeNewswire)
Sep-15-25 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
Sep-09-25 12:02AM	3 Reasons COO is Risky and 1 Stock to Buy Instead (StockStory)
Sep-03-25 01:31AM	5 Insightful Analyst Questions From CooperCompanies's Q2 Earnings Call (StockStory)
Sep-02-25 03:30PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
Sep-01-25 09:15AM	Interpreting The Cooper Companies (COO) International Revenue Trends (Zacks)
Aug-31-25 11:34PM	Medical Devices & Supplies - Diversified Stocks Q2 Recap: Benchmarking CooperCompanies (NASDAQ:COO) (StockStory)
Aug-29-25 09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
Aug-28-25 05:28PM	Why Cooper Companies Stock Sank by 13% Today (Motley Fool) -12.85%
04:25PM	These Stocks Moved the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)
04:05PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
11:48AM	Cooper Cos. Is Falling on Earnings. Why Citi Downgraded the Stock. (Barrons.com)
11:30AM	Top Stock Movers Now: Hormel, Best Buy, Snowflake, and More (Investopedia)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jay Colleen	Director	Jan 12 '26	Option Exercise	39.40	7,064	278,322	36,585	Jan 14 04:05 PM
White Albert G III	President & CEO	Jan 08 '26	Option Exercise	0.00	18,340	0	254,491	Jan 12 04:24 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '26	Option Exercise	0.00	11,518	0	29,837	Jan 12 04:24 PM
Sheffield Holly R	President, CSI	Jan 08 '26	Option Exercise	0.00	8,050	0	47,102	Jan 12 04:23 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '26	Option Exercise	0.00	12,887	0	76,007	Jan 12 04:23 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '26	Option Exercise	0.00	3,528	0	10,430	Jan 12 04:22 PM
Lucchese Cynthia L	Director	Dec 22 '25	Buy	84.06	1,784	149,963	9,445	Dec 23 04:08 PM
Rivas Maria	Director	Dec 18 '25	Buy	82.13	1,000	82,130	11,141	Dec 19 04:18 PM
Kurzius Lawrence Erik	Director	Dec 17 '25	Buy	82.50	2,000	165,000	7,777	Dec 17 05:06 PM
Sheffield Holly R	President, CSI	Dec 16 '25	Buy	80.75	1,230	99,322	39,052	Dec 16 06:36 PM
White Albert G III	President & CEO	Dec 16 '25	Buy	80.80	10,000	808,000	236,151	Dec 16 06:36 PM
Kurzius Lawrence Erik	Director	Sep 29 '25	Buy	68.39	2,000	136,780	5,777	Sep 29 08:36 PM
White Albert G III	President & CEO	Sep 05 '25	Buy	68.39	10,000	683,900	226,151	Sep 05 05:10 PM
Warner Gerard H III	President, CooperVision, Inc.	Sep 05 '25	Buy	69.23	1,450	100,384	18,319	Sep 05 04:07 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 02 '25	Buy	65.04	3,000	195,120	63,120	Sep 02 05:17 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 02 '25	Buy	65.68	1,525	100,162	22,191	Sep 02 05:16 PM
KOZY WILLIAM A	Director	Apr 01 '25	Option Exercise	0.00	2,857	0	31,149	Apr 03 04:09 PM
WEISS ROBERT S	Director	Apr 01 '25	Option Exercise	0.00	2,993	0	288,945	Apr 03 04:09 PM
Rivas Maria	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	2,721	Apr 03 04:08 PM
MADDEN TERESA S	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	12,357	Apr 03 04:08 PM
Lucchese Cynthia L	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	7,661	Apr 03 04:07 PM
Kurzius Lawrence Erik	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	3,777	Apr 03 04:07 PM
Jay Colleen	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	29,521	Apr 03 04:06 PM
Ricupati Agostino	SVP & CAO	Apr 01 '25	Option Exercise	0.00	2,076	0	9,044	Apr 03 04:06 PM

Open in Screener

OMCL

Omnicell, Inc

Feb 06 • 04:00PM ET

37.07

-2.01 -5.14 %

Healthcare • Health Information Services • USA • NASD

Peers: MDB INSP HSIC MCK PDCO GEHC ADUS EHTH AMWL HSTM

| Held by: IJR VTI VB IWM VBR VXF BOTZ IJS SPSM IWN

Index	RUT	P/E	858.10	EPS (ttm)	0.04	Insider Own	2.99%	Shs Outstand	44.88M	Perf Week	-23.57%
Market Cap	1.66B	Forward P/E	17.75	EPS next Y	2.09	Insider Trans	-3.46%	Shs Float	43.53M	Perf Month	-21.88%
Enterprise Value	1.60B	PEG	1.11	EPS next Q	0.33	Inst Own	101.39%	Short Float	6.16%	Perf Quarter	3.72%
Income	2.05M	P/S	1.40	EPS this Y	7.79%	Inst Trans	-4.69%	Short Ratio	4.69	Perf Half Y	19.47%
Sales	1.18B	P/B	1.36	EPS next Y	19.60%	ROA	0.10%	Short Interest	2.68M	Perf YTD	-18.17%
Book/sh	27.21	P/C	6.63	EPS next 5Y	16.02%	ROE	0.17%	52W High	51.84 -28.49%	Perf Year	-16.47%
Cash/sh	5.59	P/FCF	19.70	EPS past 3/5Y	-28.87% -43.00%	ROIC	0.14%	52W Low	22.66 63.59%	Perf 3Y	-35.02%
Dividend Est.	-	EV/EBITDA	17.87	Sales past 3/5Y	-2.94% 5.84%	Gross Margin	42.49%	Volatility	8.28% 4.12%	Perf 5Y	-69.62%
Dividend TTM	-	EV/Sales	1.35	EPS Y/Y TTM	-83.28%	Oper. Margin	0.44%	ATR (14)	2.42	Perf 10Y	32.44%
Dividend Ex-Date	-	Quick Ratio	1.22	Sales Y/Y TTM	6.53%	Profit Margin	0.17%	RSI (14)	22.30	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	1.43	EPS Q/Q	-113.34%	SMA20	-23.66%	Beta	0.81	Target Price	57.43
Payout	0.00%	Debt/Eq	0.16	Sales Q/Q	2.32%	SMA50	-18.69%	Rel Volume	2.80	Prev Close	39.08
Employees	3670	LT Debt/Eq	0.16	Earnings	Feb 05 BMO	SMA200	7.56%	Avg Volume	571.19K	Price	37.07
IPO	Aug 07, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.40% 0.20%	Trades		Volume	1,596,905	Change	-5.14%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-04-26	Upgrade	BofA Securities	Neutral → Buy	$70
Jan-08-26	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$60
May-14-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$35
Oct-31-24	Downgrade	BofA Securities	Buy → Neutral	$44 → $57
Aug-02-24	Upgrade	Barclays	Underweight → Equal Weight	$26 → $39
Jan-03-24	Initiated	Barclays	Underweight	$33
Nov-03-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$39 → $28
Nov-03-23	Upgrade	Piper Sandler	Neutral → Overweight	$70 → $39
Nov-03-23	Downgrade	BTIG Research	Buy → Neutral
Oct-11-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Sep-26-23	Reiterated	Wells Fargo	Underweight	$56 → $39
Aug-02-23	Downgrade	Piper Sandler	Overweight → Neutral	$66 → $70
Jul-20-23	Downgrade	Wells Fargo	Overweight → Underweight	$65 → $56
Feb-27-23	Upgrade	The Benchmark Company	Hold → Buy	$68
Nov-03-22	Downgrade	The Benchmark Company	Buy → Hold
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$130
Sep-09-22	Initiated	BofA Securities	Buy	$120
Jul-15-22	Initiated	SVB Leerink	Mkt Perform	$124
Dec-06-21	Resumed	Wells Fargo	Overweight	$203
Jun-09-21	Initiated	JP Morgan	Neutral	$146

Show Previous Ratings

Feb-06-26 12:33AM	OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook (StockStory) -5.14%
Feb-05-26 11:37PM	Omnicell Q4 Earnings Call Highlights (MarketBeat) -16.30%
04:06PM	Omnicell Inc (OMCL) Q4 2025 Earnings Call Highlights: Strong Demand and Strategic Innovations ... (GuruFocus.com)
11:56AM	Why Omnicell (OMCL) Shares Are Plunging Today (StockStory)
07:45AM	Omnicell (OMCL) Q4 Earnings Lag Estimates (Zacks)
06:53AM	Loading…
06:53AM	Omnicell's (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations (StockStory)
06:53AM	Omnicell: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results (Business Wire)
Feb-03-26 10:04PM	Omnicell Earnings: What To Look For From OMCL (StockStory) -5.46%
Feb-01-26 10:31PM	Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL) (StockStory)
Jan-30-26 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Jan-29-26 10:00AM	Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline (Zacks)
Jan-22-26 03:47AM	Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell (Zacks)
Jan-21-26 09:53AM	3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes (Zacks)
07:57AM	Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention (Zacks)
11:02PM	Loading…
Jan-19-26 11:02PM	3 Reasons to Sell OMCL and 1 Stock to Buy Instead (StockStory)
Jan-16-26 09:34AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Jan-15-26 12:09PM	CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 (Zacks)
09:36AM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
Jan-13-26 12:00PM	All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy (Zacks)
11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
08:01AM	Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 (Business Wire)
Jan-08-26 04:39PM	Stocks Settle Mixed on Sector Rotation (Barchart) +6.62%
01:43PM	Omnicell looks at long-term growth tied to cabinet replacement cycle (Investing.com)
11:23AM	Stock Indexes Mixed on Big Tech Weakness and Higher Bond Yields (Barchart)
Jan-02-26 12:10PM	CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus (Zacks)
Dec-31-25 10:30AM	KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic (Zacks)
Dec-29-25 09:48AM	Implied Volatility Surging for Omnicell Stock Options (Zacks)
Dec-23-25 12:35PM	FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform (Zacks)
Dec-17-25 07:58AM	How the OneStep Partnership Could Drive Growth for ZBH Stock (Zacks)
10:00AM	Loading…
Dec-16-25 10:00AM	Best Momentum Stocks to Buy for Dec. 16 (Zacks)
05:43AM	New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More (Zacks)
Dec-15-25 09:12AM	CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents (Zacks)
Dec-10-25 08:34AM	Is it Worth Retaining NEOG Stock in Your Portfolio for Now? (Zacks)
08:31AM	Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? (Zacks)
Dec-09-25 07:28AM	ALGN Stock Rises on Thailand Launch of Invisalign With MAOB (Zacks)
07:27AM	Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
07:26AM	RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort (Zacks)
Dec-08-25 11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks) +7.54%
08:00AM	Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management (Business Wire)
07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)
Dec-07-25 11:34PM	1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off (StockStory)
Dec-05-25 08:48AM	MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System (Zacks)
08:31AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Dec-04-25 11:30AM	Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report? (Zacks)
Dec-03-25 11:30AM	Hims & Hers Health (HIMS) Down 15.1% Since Last Earnings Report: Can It Rebound? (Zacks) +5.25%
Nov-27-25 09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 30.93%: Read This Before Placing a Bet (Zacks)
Nov-20-25 04:01PM	Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Nov-10-25 09:55AM	Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.53%: Here's is How to Trade (Zacks)
Nov-04-25 11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
09:21AM	Buy 5 Stocks With Extensive Robotics Application for the Rest of 2025 (Zacks)
Nov-03-25 12:20PM	Earnings Estimates Moving Higher for Omnicell (OMCL): Time to Buy? (Zacks)
11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks)
Oct-30-25 06:45PM	Why Omnicell Stock Crushed the Market Today (Motley Fool) +13.56%
04:31PM	Omnicell Inc (OMCL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
02:35PM	Why Omnicell (OMCL) Stock Is Trading Up Today (StockStory)
07:45AM	Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:54AM	Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars (StockStory)
06:40AM	Omnicell: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Third Quarter 2025 Financial Results (Business Wire)
Oct-28-25 11:15PM	Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Oct-27-25 10:00AM	Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 09:55AM	Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High? (Zacks)
Oct-23-25 10:00AM	Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline (Zacks)
09:40AM	Are Investors Undervaluing Omnicell (OMCL) Right Now? (Zacks)
Oct-21-25 10:46PM	Omnicell, Inc. (OMCL): A Bull Case Theory (Insider Monkey)
05:19AM	10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? (Zacks)
Oct-17-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Oct-14-25 03:00PM	NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings (Zacks)
Oct-07-25 09:40AM	Is Omnicell (OMCL) Stock Undervalued Right Now? (Zacks)
08:23AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Oct-06-25 04:01PM	Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025 (Business Wire)
Oct-02-25 12:43AM	1 Stock Under $50 with Promising Prospects and 2 Facing Challenges (StockStory)
Oct-01-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
09:30AM	BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience (Zacks)
Sep-30-25 10:05AM	OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? (Zacks)
Sep-18-25 09:40AM	Is Omnicell (OMCL) a Great Value Stock Right Now? (Zacks)
Sep-15-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Sep-12-25 03:35AM	The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM (Zacks)
Sep-11-25 03:00PM	NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy (Zacks)
09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 39.36%: Read This Before Placing a Bet (Zacks)
Sep-05-25 12:34AM	3 Low-Volatility Stocks We Steer Clear Of (StockStory)
Sep-03-25 11:30AM	Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report? (Zacks)
Sep-01-25 12:02AM	Omnicell (OMCL): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Aug-27-25 11:38PM	Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
Aug-26-25 12:20PM	Earnings Estimates Rising for Omnicell (OMCL): Will It Gain? (Zacks)
09:55AM	Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.18%: Here's is How to Trade (Zacks)
Aug-25-25 04:05PM	Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer (Business Wire)
Aug-14-25 09:34AM	Pharmacy Automation Company Evaluation Report 2025 \| BD, Omnicell, and Capsa Healthcare Lead in Medical Technology, Pharmacy Automation, and Medication Management Solutions (GlobeNewswire)
Aug-13-25 12:04AM	OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance (StockStory)
Aug-12-25 11:50PM	5 Must-Read Analyst Questions From Omnicell's Q2 Earnings Call (StockStory)
Aug-01-25 09:55AM	Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High? (Zacks)
Jul-31-25 07:45AM	Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:59AM	Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
06:43AM	Omnicell: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Second Quarter 2025 Results (Business Wire)
Jul-30-25 01:09PM	Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings? (Zacks)
11:40AM	OMCL vs. DOCS: Which Stock Is the Better Value Option? (Zacks)
Jul-29-25 11:04PM	Earnings To Watch: Omnicell (OMCL) Reports Q2 Results Tomorrow (StockStory)

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Jan 08 '26	Sale	49.90	6,106	304,689	91,674	Jan 12 04:05 PM
Manley Corey J	Officer	Jan 08 '26	Proposed Sale	49.90	6,106	304,689		Jan 08 10:30 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Dec 16 '25	Sale	43.30	278	12,037	97,780	Dec 17 04:05 PM
Manley Corey J	Officer	Dec 16 '25	Proposed Sale	43.30	278	12,037		Dec 16 09:48 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Dec 03 '25	Sale	39.90	6,106	243,629	98,282	Dec 05 04:05 PM
Manley Corey J	Officer	Dec 03 '25	Proposed Sale	39.90	6,106	243,629		Dec 03 04:39 PM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Dec 01 '25	Option Exercise	27.70	28,250	782,525	414,898	Dec 03 04:05 PM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Dec 01 '25	Sale	35.97	28,250	1,016,093	386,648	Dec 03 04:05 PM
Randall Lipps	Officer	Dec 01 '25	Proposed Sale	35.97	28,250	1,016,092		Dec 01 01:12 PM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Nov 17 '25	Sale	34.90	3,473	121,208	104,388	Nov 18 04:13 PM
Manley Corey J	Officer	Nov 17 '25	Proposed Sale	34.90	3,473	121,208		Nov 17 10:36 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Sep 12 '25	Sale	33.25	3,880	129,010	110,653	Sep 16 04:09 PM
Manley Corey J	Officer	Sep 12 '25	Proposed Sale	33.25	3,880	129,010		Sep 12 11:36 AM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Mar 14 '25	Buy	33.13	10,561	349,874	333,610	Mar 18 04:13 PM

COO

Cooper Companies, Inc

OMCL

Omnicell, Inc

Upgrade your FINVIZ experience